In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

The in vitro activity of a novel 8-methoxyquinolone, BAY 12-8039, against recent clinical isolates of Streptococcus pneumoniae (n = 404), Haemophilus influenzae (n = 330), and Moraxella catarrhalis (n = 250) was evaluated. Activity was compared to those of six other fluoroquinolones: ciprofloxacin,...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Brueggemann, A, Kugler, K, Doern, G
स्वरूप: Journal article
भाषा:English
प्रकाशित: 1997
_version_ 1826292963701948416
author Brueggemann, A
Kugler, K
Doern, G
author_facet Brueggemann, A
Kugler, K
Doern, G
author_sort Brueggemann, A
collection OXFORD
description The in vitro activity of a novel 8-methoxyquinolone, BAY 12-8039, against recent clinical isolates of Streptococcus pneumoniae (n = 404), Haemophilus influenzae (n = 330), and Moraxella catarrhalis (n = 250) was evaluated. Activity was compared to those of six other fluoroquinolones: ciprofloxacin, clinafloxacin, levofloxacin, ofloxacin, sparfloxacin and trovafloxacin. BAY 12-8039 and clinafloxacin had the highest levels of activity against S. pneumoniae, both with a MIC at which 90% of the isolates were inhibited (MIC90) of 0.06 microg/ml. Trovafloxacin and sparfloxacin were the next most active agents versus S. pneumoniae (MIC90s = 0.12 microg/ml). No differences in activity against penicillin-susceptible, -intermediate, or -resistant strains of S. pneumoniae were noted for any of the fluoroquinolones tested. MIC90s for the seven fluoroquinolones ranged from 0.008 to 0.06 microg/ml versus H. influenzae and from 0.008 to 0.12 microg/ml for M. catarrhalis. The MICs for two strains of S. pneumoniae and one strain of H. influenzae were noted to be higher than those for the general population of organisms for all of the fluoroquinolones tested. Finally, the activity of BAY 12-8039 versus S. pneumoniae was found to be diminished when MIC determinations were performed with incubation of agar dilution plates or broth microdilution trays in 5 to 7% CO2 versus ambient air.
first_indexed 2024-03-07T03:22:47Z
format Journal article
id oxford-uuid:b800fbf8-306d-44fd-b0ec-df02d9e8e699
institution University of Oxford
language English
last_indexed 2024-03-07T03:22:47Z
publishDate 1997
record_format dspace
spelling oxford-uuid:b800fbf8-306d-44fd-b0ec-df02d9e8e6992022-03-27T04:52:51ZIn vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b800fbf8-306d-44fd-b0ec-df02d9e8e699EnglishSymplectic Elements at Oxford1997Brueggemann, AKugler, KDoern, GThe in vitro activity of a novel 8-methoxyquinolone, BAY 12-8039, against recent clinical isolates of Streptococcus pneumoniae (n = 404), Haemophilus influenzae (n = 330), and Moraxella catarrhalis (n = 250) was evaluated. Activity was compared to those of six other fluoroquinolones: ciprofloxacin, clinafloxacin, levofloxacin, ofloxacin, sparfloxacin and trovafloxacin. BAY 12-8039 and clinafloxacin had the highest levels of activity against S. pneumoniae, both with a MIC at which 90% of the isolates were inhibited (MIC90) of 0.06 microg/ml. Trovafloxacin and sparfloxacin were the next most active agents versus S. pneumoniae (MIC90s = 0.12 microg/ml). No differences in activity against penicillin-susceptible, -intermediate, or -resistant strains of S. pneumoniae were noted for any of the fluoroquinolones tested. MIC90s for the seven fluoroquinolones ranged from 0.008 to 0.06 microg/ml versus H. influenzae and from 0.008 to 0.12 microg/ml for M. catarrhalis. The MICs for two strains of S. pneumoniae and one strain of H. influenzae were noted to be higher than those for the general population of organisms for all of the fluoroquinolones tested. Finally, the activity of BAY 12-8039 versus S. pneumoniae was found to be diminished when MIC determinations were performed with incubation of agar dilution plates or broth microdilution trays in 5 to 7% CO2 versus ambient air.
spellingShingle Brueggemann, A
Kugler, K
Doern, G
In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
title In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
title_full In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
title_fullStr In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
title_full_unstemmed In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
title_short In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
title_sort in vitro activity of bay 12 8039 a novel 8 methoxyquinolone compared to activities of six fluoroquinolones against streptococcus pneumoniae haemophilus influenzae and moraxella catarrhalis
work_keys_str_mv AT brueggemanna invitroactivityofbay128039anovel8methoxyquinolonecomparedtoactivitiesofsixfluoroquinolonesagainststreptococcuspneumoniaehaemophilusinfluenzaeandmoraxellacatarrhalis
AT kuglerk invitroactivityofbay128039anovel8methoxyquinolonecomparedtoactivitiesofsixfluoroquinolonesagainststreptococcuspneumoniaehaemophilusinfluenzaeandmoraxellacatarrhalis
AT doerng invitroactivityofbay128039anovel8methoxyquinolonecomparedtoactivitiesofsixfluoroquinolonesagainststreptococcuspneumoniaehaemophilusinfluenzaeandmoraxellacatarrhalis